Atu-111

N/A

Report date: 2026/02/27 11:21:42
NME

Base Information

Drug NameAtu-111
Drug Alias NameAtu-111Atu111
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiopoietin-2 inhibitors
TargetsAngiopoietin-2
Therapy Area/IndicationsAcute Lung InjurySepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSilence Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHannover Medical SchoolSilence Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsAcute Lung InjurySepsis

Other Information

ATC CodeN/A
Related LinksN/A